Literature DB >> 16052596

Contrasting roles of plasminogen deficiency in different rheumatoid arthritis models.

Jinan Li1, Yongzhi Guo, Rikard Holmdahl, Tor Ny.   

Abstract

OBJECTIVE: To investigate the contrasting roles of plasminogen deficiency between models of collagen-induced arthritis (CIA) and antigen-induced arthritis (AIA).
METHODS: We developed a new animal model of arthritis, which we have called local injection-induced arthritis (LIA). In this model, we replaced methylated bovine serum albumin, which is normally used as an immunogen and is injected intraarticularly into the knee joint, with type II collagen (CII) to induce AIA. The severity of CIA, LIA, and AIA in wild-type and plasminogen-deficient mice was evaluated by clinical scoring or histologic grading. Necrosis was determined by histology and immunohistochemistry.
RESULTS: After CII immunization alone, wild-type mice developed arthritis in most of the paws as well as in the knee joints, whereas plasminogen-deficient mice were totally resistant to the disease. Local knee injections of CII or saline slightly enhanced the severity of the knee arthritis in wild-type mice during a 60-day experimental period. Unexpectedly, the plasminogen-deficient mice also developed arthritis in joints that were injected with CII or saline. However, the arthritis was milder than that in their wild-type littermates. Sustained tissue necrosis was found only in the plasminogen-deficient mice after the local injection.
CONCLUSION: Our data show that both the antigen and the joint trauma caused by the local injection are critical to explaining the contrasting roles of plasminogen deficiency in CIA and AIA. This further indicates that CIA and AIA have distinct pathogenic mechanisms. The data also suggest that plasmin may be required for the induction of these arthritis models that are critically dependent on complement activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16052596     DOI: 10.1002/art.21229

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  8 in total

1.  Identification of potential serum biomarkers for rheumatoid arthritis by high-resolution quantitative proteomic analysis.

Authors:  Yongjing Cheng; Yuling Chen; Xiaolin Sun; Yuhui Li; Cibo Huang; Haiteng Deng; Zhanguo Li
Journal:  Inflammation       Date:  2014-10       Impact factor: 4.092

2.  Fibrinolysis is down-regulated in mouse collagen-induced arthritis, but its normalization does not alleviate the course of disease.

Authors:  Jakub Kwieciński; Elisabet Josefsson; Tao Jin
Journal:  Inflamm Res       Date:  2011-07-24       Impact factor: 4.575

Review 3.  Serine proteinases in the turnover of the cartilage extracellular matrix in the joint: implications for therapeutics.

Authors:  David J Wilkinson; Maria Del Carmen Arques; Carmen Huesa; Andrew D Rowan
Journal:  Br J Pharmacol       Date:  2018-03-30       Impact factor: 8.739

4.  Polymorphisms in genes controlling inflammation and tissue repair in rheumatoid arthritis: a case control study.

Authors:  Marieke Emonts; Mieke J M W Hazes; Jeanine J Houwing-Duistermaat; Christa E van der Gaast-de Jongh; Lisette de Vogel; Huub K H Han; Jacques M G W Wouters; Jon D Laman; Radboud J E M Dolhain
Journal:  BMC Med Genet       Date:  2011-03-07       Impact factor: 2.103

5.  Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.

Authors:  Christine M De Nardo; Jason C Lenzo; Jarrad Pobjoy; John A Hamilton; Andrew D Cook
Journal:  Arthritis Res Ther       Date:  2010-10-25       Impact factor: 5.156

6.  Measurements in the Blood of BDNF for RA Patients and in Response to Anti-TNF Treatment Help Us to Clarify the Magnitude of Centrally Related Pain and to Explain the Relief of This Pain upon Treatment.

Authors:  Sture Forsgren; Ola Grimsholm; Tore Dalén; Solbritt Rantapää-Dahlqvist
Journal:  Int J Inflam       Date:  2011-06-08

Review 7.  The Urokinase Plasminogen Activation System in Rheumatoid Arthritis: Pathophysiological Roles and Prospective Therapeutic Targets.

Authors:  Benjamin J Buckley; Umar Ali; Michael J Kelso; Marie Ranson
Journal:  Curr Drug Targets       Date:  2019       Impact factor: 3.465

8.  The Coagulation Factors Fibrinogen, Thrombin, and Factor XII in Inflammatory Disorders-A Systematic Review.

Authors:  Kerstin Göbel; Susann Eichler; Heinz Wiendl; Triantafyllos Chavakis; Christoph Kleinschnitz; Sven G Meuth
Journal:  Front Immunol       Date:  2018-07-26       Impact factor: 7.561

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.